Saffron Tea

1. What conditions has Saffron Tea been studied for?

• Psychological well-being in postmenopausal women: Specifically, “happiness” and depressive symptoms/mental health during menopause were studied in a randomized clinical trial using saffron herbal tea.

• Human absorption/metabolism (pharmacokinetics) of saffron carotenoids: One study measured plasma levels of crocetin after consuming saffron tea, addressing bioavailability rather than a disease condition.

• Food adulteration detection relevant to “fake saffron”: One abstract developed a fluorescent nanosensor to detect tartrazine, a dye used as fake saffron. This is not a health condition treated by saffron tea, but it relates to product authenticity and potential exposure to an additive described as “health-threatening.”

2. Does it work in treating those conditions? Summarize the evidence.

• Menopause-associated mood/happiness outcomes: In a randomized clinical trial (2021) of 72 postmenopausal women, the intervention group consumed saffron tea made from 30 mg dried saffron stigmas daily (boiled in 300 mL water for 10–15 minutes) with white rock candy.

  Findings: The intervention group’s Oxford Happiness Questionnaire score increased from 42.93 ± 8.54 to 61.58 ± 8.24 (paired t-test p < 0.001), while the control group showed no significant change (p = 0.861). After the intervention, there was a significant between-group difference (p < 0.001).

  Interpretation/limits: This supports benefit for self-reported happiness in this population under the tested regimen. However, the abstract does not describe blinding, placebo matching, or details of the control beverage; the tea was consumed with rock candy, which could influence experience/expectancy. Outcomes were questionnaire-based rather than clinician-diagnosed depression.

• Absorption/metabolism (not treatment efficacy): In a small pharmacokinetic study (4 healthy volunteers), one cup of saffron tea made with 200 mg saffron in 80°C water for 5 minutes led to measurable plasma crocetin. This demonstrates systemic exposure to at least one bioactive saffron metabolite but does not establish clinical efficacy for any condition.

3. What health benefits does it have?

• Improved happiness / mood-related outcomes in postmenopausal women: The clinical trial reported a substantial increase in happiness scores after daily saffron tea (30 mg stigmas/day) over the study period, and the authors conclude it had a “positive effect on reducing depression and increasing the happiness score.”

• Demonstrated bioavailability of crocetin after tea consumption: After one cup of saffron tea (200 mg saffron), plasma crocetin reached 1.24–3.67 μM at 2 hours and remained detectable at 0.10–0.24 μM at 24 hours. This supports that saffron tea can deliver absorbable carotenoid-derived compounds into circulation, which is a prerequisite for systemic effects.

• Potential consumer safety benefit via adulteration detection (indirect): The tartrazine assay is not a health benefit of saffron tea itself, but it highlights a real-world issue—fake saffron adulteration with tartrazine—and provides a method for selective detection at very low concentrations (reported range 3.3–20.0 nM). Avoiding adulterants could be a practical safety-related benefit when sourcing saffron products.

4. Does it have any downsides or side effects?

• Side effects were not reported in the provided abstracts: The menopause trial abstract does not describe adverse events, tolerability, dropout due to side effects, or safety labs. The pharmacokinetic study also does not mention adverse effects.

• Product quality/adulteration risk: One abstract emphasizes that tartrazine is “commonly used as fake saffron” and is described as “health-threatening.” While this does not prove harm from saffron tea, it highlights a potential downside: consumers may unknowingly ingest adulterants if the product is not authentic.

• Dose and preparation variability: The abstracts used very different saffron amounts per cup (30 mg vs 200 mg) and different brewing conditions. This variability can affect exposure and potentially side effects, but the abstracts do not provide enough data to define a safe upper limit or common adverse reactions.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not evaluate pharmacogenomic effects (no genotype-stratified analyses, no gene–response associations, and no discussion of genetic variants affecting saffron metabolism or response).

• What can be inferred (limited): The pharmacokinetic study observed that 25–50% of circulating crocetin was the cis-isomer, suggesting in vivo isomerization. This indicates metabolism/biotransformation occurs, but the study does not link this to genetic variation.

• Bottom line: Based on these abstracts alone, there is no evidence that saffron tea is specifically beneficial or harmful for any particular genetic variants.

References

1. Detection of tartrazine in fake saffron containing products by a sensitive optical nanosensor.
   Sheida Zoughi, Farnoush Faridbod, Amir Amiri, Mohammad Reza Ganjali (2021) - Food chemistry
2. The effect of Crocus sativus L. (saffron) herbal tea on happiness in postmenopausal women: a randomized controlled trial.
   Hamed Delam, Zahra Keshtkaran, Nasrin Shokrpour, Ahmadreza Eidi, Mohammad-Rafi Bazrafshan (2023) - BMC complementary medicine and therapies
3. A new validated SPE-HPLC method for monitoring crocetin in human plasma--application after saffron tea consumption.
   Dimitra G Chryssanthi, Fotini N Lamari, Constantine D Georgakopoulos, Paul Cordopatis (2011) - Journal of pharmaceutical and biomedical analysis